VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018
VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update
VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits
VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update
VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock
VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board
VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update
VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update
